Where do probiotic foods, beverages, and supplements stand today?
Recent stability tests evaluated ProDura’s ability to survive different pH and storage conditions for beverage products.
Boswellia Supplement Reduces Symptoms of IBS in New Study, with Fewer Side Effects than Drug Treatments
Indena says that Casperome’s “full natural bouquet of triterpenoids” may provide quick relief from symptoms of Irritable Bowel Syndrome, with fewer side effects compared to standard drug treatments.
The 221-infant study found that the three probiotic strains present in Lallemand’s ProbioKid formula—Lactobacillus helveticus Rosell-52, Bifidobacterium infantis Rosell-33, and Bifidobacterium bifidum Rosell-71—were safe and well-tolerated.
The newly added probiotic strains include Faecalibacterium prausnitzii and Eubacterium hallii, two strains that the company says are “widely regarded as primary candidates for next-generation probiotics.”
DSHEA Expert Says FDA’s “Misreading” of the Term “Dietary Substance” in NDI Draft Guidance Is Biggest Hurdle for Synthetic Botanicals, Probiotics
Attorney Scott Bass, who helped draft the DSHEA law of 1994, says that Congress did not intend “dietary substances” only to be limited to ingredients that are nutritional—and that this should mean that synthetic botanicals and probiotics count as dietary ingredients and be eligible for use in dietary supplements.
According to the study authors, preliminary animal data indicate that microorganisms are transferred to the placenta and fetus intestinal tract during pregnancy, and suggest that the fetal intestine is not sterile but rather populated with microorganisms.
The in vitro study found that the presence of BC30 both increased protein digestion uptake in the upper gastrointestinal tract and promoted a healthier environment in the colon.
The study authors say that the combination of Deerland Enzyme and Probiotics’ DE111 Bacillus subtilis probiotic strain with “adequate post-workout nutrition” improved body composition and overall athletic performance and shows potential for use by both professional and recreational athletes.
At IFT 2017, a Tate & Lyle microbiologist discussed opportunities and hurdles that microbiome researchers must now overcome as they focus on studies in human populations.